Figure 2
From: Patient-reported sexual toxicity after radiation therapy in long-term prostate cancer survivors
The effect of time since radiation therapy on symptom prevalence for prostate cancer survivors displayed by radiation therapy regimen. Time to follow-up in intervals shorter than 3 years, 3–5 years, 5–7.5 years and longer than 7.5 years displayed on the x axis and symptom prevalence on the y axis. Primary external beam radiation therapy (EBRT) displayed in the dark grey bars, EBRT in combination with brachytherapy (EBRT+BT) displayed in the light grey bars, and salvage EBRT displayed in the white bars; the dotted line is the prevalence in reference men. The numbers preceding each symptom refer to the associated question number in Table 2.
